FOXJ2 and ulcerative colitis: Serum DIDO1-Ab and FOXJ2-Ab levels were significantly higher in patients with rheumatoid arthritis and SLE (but not in those with Sjögren’s syndrome or ulcerative colitis) than in HDs (Supplementary Table S2).